FDA okays Eli Lilly’s new weight-loss pill, expanding options for millions
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
This makes VLCC the sole institution in the country authorised to conduct in-person NCLC exams
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The new assay consolidates screening for four major viral threats into a single workflow
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
Subscribe To Our Newsletter & Stay Updated